Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moyle

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
International Journal of STD & AIDS|November 18, 2003
The Assessing Patients' Preferred Treatments (APPT-1) studyG Moyle
Drugs|February 24, 2001
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapyG Moyle
HIV Medicine|December 12, 2001
Resistance and cross-resistance to abacavirG Moyle
Current Opinion in Infectious Diseases|April 30, 2002
Searching for solutions: the African crisis and the need for safe, simple and cheap prevention and therapyG Moyle
Drugs|August 13, 2016
Amprenavir : A Viewpoint by Graeme MoyleG Moyle
Expert Opinion on Investigational Drugs|July 5, 2005
Triple nucleoside analogue antiretroviral therapy: expanding the treatment approaches for management of HIV infectionG Moyle
Current Opinion in Infectious Diseases|October 13, 2006
Treatment guidelines and clinical realitiesG Moyle
British Journal of Hospital Medicine|June 4, 1997
Saquinavir in the management of HIV infectionG Moyle
International Journal of STD & AIDS|November 18, 2003
Once-daily therapy: less is moreG Moyle
Expert Opinion on Investigational Drugs|July 5, 2005
The role of combinations of HIV protease inhibitors in the management of persons with HIV infectionG Moyle
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
International Journal of STD & AIDS|November 18, 2003
The Assessing Patients' Preferred Treatments (APPT-1) studyG Moyle
Drugs|February 24, 2001
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapyG Moyle
HIV Medicine|December 12, 2001
Resistance and cross-resistance to abacavirG Moyle
Current Opinion in Infectious Diseases|April 30, 2002
Searching for solutions: the African crisis and the need for safe, simple and cheap prevention and therapyG Moyle
Drugs|August 13, 2016
Amprenavir : A Viewpoint by Graeme MoyleG Moyle
Expert Opinion on Investigational Drugs|July 5, 2005
Triple nucleoside analogue antiretroviral therapy: expanding the treatment approaches for management of HIV infectionG Moyle
Current Opinion in Infectious Diseases|October 13, 2006
Treatment guidelines and clinical realitiesG Moyle
British Journal of Hospital Medicine|June 4, 1997
Saquinavir in the management of HIV infectionG Moyle
International Journal of STD & AIDS|November 18, 2003
Once-daily therapy: less is moreG Moyle
Expert Opinion on Investigational Drugs|July 5, 2005
The role of combinations of HIV protease inhibitors in the management of persons with HIV infectionG Moyle
Pageof 15